First Light Asset Management, LLC Sutro Biopharma, Inc. Transaction History

First Light Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.41 - $8.95 $5.7 Million - $15 Million	-1,672,497 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$7.78 - $15.31 $4.47 Million - $8.79 Million	-574,091 Reduced 25.55%	1,672,497 $13.7 Million
Q4 2021 Feb 14, 2022	BUY	$14.25 - $23.53 $785,873 - $1.3 Million	55,149 Added 2.52%	2,246,588 $33.4 Million
Q3 2021 Nov 12, 2021	BUY	$16.88 - $22.38 $2 Million - $2.65 Million	118,564 Added 5.72%	2,191,439 $41.4 Million
Q2 2021 Aug 13, 2021	BUY	$18.03 - $23.82 $260,136 - $343,674	14,428 Added 0.7%	2,072,875 $38.5 Million
Q1 2021 May 17, 2021	BUY	$20.29 - $27.54 $25 Million - $33.9 Million	1,231,346 Added 148.87%	2,058,447 $46.9 Million
Q4 2020 Feb 16, 2021	BUY	$10.16 - $23.98 $8.4 Million - $19.8 Million	827,101 New	827,101 $18 Million

137

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $140M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.